Entrada Therapeutics, Inc. SEC filings TRDA
Entrada Therapeutics, Inc. has 472 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2023 | — |
| CORRESP | Letter to the SEC | Dec 6, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2023 | — |
| EFFECT | Filing | Nov 7, 2022 | — |
| CORRESP | Letter to the SEC | Nov 4, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| EFFECT | Filing | Oct 28, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 28, 2021 | — |
| CERT | Filing | Oct 27, 2021 | — |
| 8-A12B | Filing | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 8, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 28, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 20, 2021 | — |
| DRSLTR | Filing | Sep 15, 2021 | — |
| DRS/A | Filing | Sep 15, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2021 | — |
| DRS | Filing | Aug 6, 2021 | — |
| D | Filing | Apr 13, 2021 | — |
| D/A | Filing | Dec 26, 2019 | — |
| D | Filing | Dec 26, 2018 | — |
| D | Filing | Nov 10, 2016 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1689375
- Former names
- CycloPorters, Inc. (until Nov 10, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.